Search results for: 'Cancer Diagnostics Market'

Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. The global IVD market size was $47.30 billion in 2013; it is expected to reach $62.63 billion in 2017, at a compound annual growth rate of 7.3%. Because of stagnating mature markets, comp...

Computed tomography (CT) is a sophisticated imaging technology that combines X-ray measurements obtained from multiple angles and processes them using computer algorithms to generate cross-sectional images or tomograms. The tomograms are further reconstructed into a 3D representation of organs or tissues, allowing precise visualization of the inter...

This research study provides an analysis of the in vitro diagnostics (IVD) market in India. It quantifies market size, provides insight into the burden of diseases in India, and examines market dynamics from 2007 to 2017. It provides an in-depth analysis of the competitive environment by highlighting the competitive structure, diagnostic service la...

23 Mar 2017  |  Asia Pacific  |  Market Research

APAC Molecular Diagnostics Market, Forecast to 2021

Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth

Infographics

×

The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identif...

The increase in HIV awareness among people has led to the demand for effective diagnostic products and solutions. As a result, some new products based on NAT technology and non-NAT technology platforms are being developed. This research service analyses the HIV diagnostics market in Europe, particularly, HIV NAT diagnostics and HIV Immunodiagnostic...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...

This study covers three countries in East Africa: Kenya, Uganda, Tanzania and their clinical diagnostics industry. Market, examining drivers and restraints for growth, pricing, distribution, technology, legislation, demand and geographical trends. Following from these, market growth for regional and market segments are forecasted. In addition, an i...

This research service encompasses a comprehensive analysis of minimally-invasive and non-invasive biopsy platforms that enable enhanced tumor profiling, treatment monitoring and precision oncology applications. This service primarily focuses on the use of circulating tumor DNA (ctDNA) circulating tumor cells (CTCs) and extracellular vesicles (EVs),...

This research service focuses on the market for such therapeutics. It aims to introduce market opportunity for breast cancer therapeutics in the United States, and the top seven markets in Europe (Germany, France, the United Kingdom, Spain, Italy, Benelux and Scandinavia). For the purpose of analysis, a market forecast for the total world breast ca...